About Cytoswim
Cytoswim is a Healthcare company based in Coventry (United Kingdom) founded in 2019. Sperm selection tools for assisted reproduction are developed. Cytoswim has raised $129.35 thousand across 2 funding rounds from investors including Oxford Technology and UK Research and Innovation. The company has 4 employees. Its chief executive, as recorded, is Max Meissner. Cytoswim offers products and services including SpermAlign. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Semen Collection. Its legal entity is CYTOSWIM LTD.
Company details
Cytoswim was founded in 2019 and is based in Coventry, United Kingdom. Tools for sperm selection in assisted reproduction are developed by the company, focusing on advancements in reproductive medicine. Operations center on biotechnology solutions to improve fertility treatments. The CEO position is held by Max Meissner. Services target healthcare providers in the assisted reproduction sector.
- Headquarters Coventry, United Kingdom
- Employees 4
- SectorsHealthcare
- Website cytoswim.com
- Social LinkedIn
- Legal Name Cytoswim Ltd
- Date of Incorporation 21 Feb, 2019
- Jurisdiction COVENTRY, ENGLAND
- Total Equity Funding$129.35K (USD)
in 2 rounds
- Latest Funding Round$394.7K (USD), Grant
Jun 2019
- InvestorsOxford Technology
& 1 more
- Employee Count4
Products & Services of Cytoswim
Cytoswim offers a comprehensive portfolio of products and services, including SpermAlign.
Tool for enhancing sperm quality in assisted reproductive technology procedures.
Funding Insights of Cytoswim
Cytoswim has successfully raised a total of $129.35K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $394.7 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $129,354
- Total Rounds 2
- Last Round Grant — $394,695
- First Round $129,354
(Apr 2019)
- Investors Count 2
All 2 funding rounds of Cytoswim with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $394,695 | Grant | – | – | |
| Apr 2019 | $129,354 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Cytoswim
Cytoswim has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Oxford Technology and UK Research and Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage micro-VC investments are focused on UK companies. | 1983 | oxfordtechnology.com | ||
Research and innovation funding is managed for UK advancement. | 2018 | ukri.org | Swindon, United Kingdom |
Investor details for Cytoswim
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cytoswim
1 people are tracked at Cytoswim (1 in leadership); the tracked headcount is 4.
| Name | Role | Group |
|---|---|---|
Max Meissner | CEO | Leadership |
Complete people profiles for Cytoswim
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cytoswim
3 dated milestones of Cytoswim, from founding to its latest funding, stage changes and deals.
- Founded Cytoswim is founded.
- Funding First funding round of $129K.
- Funding Latest funding round, Grant, of $395K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cytoswim
Cytoswim was founded in 2019.
Cytoswim is headquartered in Coventry, United Kingdom.
Max Meissner is the CEO of Cytoswim, as recorded in our data.
Cytoswim is a funded company, having raised a total of $129.35K across 2 funding rounds to date. The company's 1st funding round was a Seed of $129.35K, raised on Apr 2019.
Cytoswim has 4 employees.
Cytoswim was founded in 2019 and is based in Coventry, United Kingdom. Tools for sperm selection in assisted reproduction are developed by the company, focusing on advancements in reproductive medicine. Operations center on biotechnology solutions to improve fertility treatments. The CEO position is held by Max Meissner. Services target healthcare providers in the assisted reproduction sector.
Cytoswim offers SpermAlign.
Cytoswim has 2 investors. Key investors include Oxford Technology, and UK Research and Innovation.
Cytoswim operates through Cytoswim Ltd.